Pre-Market Stocks Recap: Harris (NYSE:HRS), Aramark(NYSE:ARMK), Sucampo Pharmaceuticals,(NASDAQ:SCMP), WP Glimcher (NYSE:WPG)

Pre-Market Stocks Recap: Harris (NYSE:HRS), Aramark(NYSE:ARMK), Sucampo Pharmaceuticals,(NASDAQ:SCMP), WP Glimcher (NYSE:WPG)

- in Business & Finance
0

On Tuesday, Harris Corporation (NYSE:HRS)’s shares declined -1.96% to $82.93.

Harris Corporation (HRS) stated fiscal 2015 fourth quarter results, which comprised of results of Exelis Inc. following the May 29, 2015 acquisition closing date.

Revenue in the fourth quarter of fiscal 2015 was $1.53 billion, contrast with $1.33 billion in the preceding year. GAAP loss from ongoing operations was $56 million, or $0.51 per diluted share. Non-GAAP income from ongoing operations in the fourth quarter was $148 million, or $1.32 per diluted share, and excluded acquisition-related costs and charges for restructuring and other items. The net benefit from the Exelis acquisition to Harris non-GAAP income from ongoing operations was $0.09 per diluted share. Preceding year GAAP income from ongoing operations was $138 million, or $1.28 per diluted share.

Orders in the fourth quarter were $1.53 billion contrast with $1.09 billion in the preceding year. Free cash flow (net cash offered by operating activities less capital expenditures) in the fourth quarter was $413 million contrast with $334 million in the preceding year.

Harris Corporation, together with its auxiliaries, operates as an international communications and information technology company worldwide. The company operates through RF Communications, Integrated Network Solutions, and Government Communications Systems segments.

Aramark (NYSE:ARMK)’s shares dropped -0.62% to $32.09.

The World Meeting of Families — Philadelphia 2015 recently declared Aramark (ARMK), the global provider of award-winning services in food, facilities administration and uniforms, headquartered in Philadelphia, as the official food and beverage provider for the visit of Pope Francis in Philadelphia. Formerly declared as the official retail partner for the World Meeting of Families — Philadelphia in June 2015, Aramark will serve the more than 1 million predictable pilgrims, who will gather on the Benjamin Franklin Parkway and on Independence Mall in Center City, for the historic events featuring Pope Francis on Saturday, September 26 and Sunday, September 27.

Aramark will offer a variety of menu options the weekend of the Papal events, counting grilled and grab-and-go sandwiches, wraps, fruit and beloved Philadelphia treats. The menu will also comprise on-the-go, family-friendly WMOF picnic bags and snack boxes. To enhance the local and international food offerings, Aramark is coordinating local food truck vendors as partners for the Papal visit weekend. There will also be a wide-variety of beverage options at stands, but it is important to note that Papal events will not feature any alcoholic beverages for sale.

Aramark provides food, facilities, and uniform services to education, healthcare, business and industry, sports, leisure, and corrections clients primarily in North America. The company offers managed services, counting dining, catering, food service administration, convenience-oriented retail operations, grounds and facilities maintenance, custodial, energy and construction administration, and capital project administration.

At the end of Tuesday’s trade, Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP)‘s shares surged 1.53% to $24.60.

Sucampo Pharmaceuticals, Inc. (SCMP) stated merged financial results for the second quarter ended June 30, 2015.

Sucampo stated year-over-year growth of 45% to $34.9 million in total revenue, 16% to $16.1 million in product royalty revenue and 92% to $14.5 million in product sales revenue. Sucampo stated net income of $9.6 million and fully-diluted earnings per share (EPS) of $0.21 during the second quarter of 2015, contrast to net income of $1.6 million and fully-diluted EPS of $0.04 in the same period in 2014.

Sucampo Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the research and development of proprietary drugs in the Americas, Europe, and Asia. It is developing prostones, which are ion channel activators, to treat gastrointestinal, ophthalmic, and oncology-based inflammatory disorders, in addition to other therapeutic applications of drug technologies.

WP Glimcher Inc (NYSE:WPG), ended its Tuesday’s trading session with 0.46% gain, and closed at $13.07.

WP Glimcher Inc. (WPG), a premier retail real estate investment trust specializing in the ownership, administration and development of shopping centers, recently stated financial results and operating data for the second quarter ended June 30, 2015.

Second Quarter Results

Same property net operating income (“NOI”) for the second quarter of 2015 for the Company’s core properties was flat contrast to the second quarter of 2014. Ending occupancy for the core properties was 92.3% as of June 30, 2015, contrast to 92.9% as of June 30, 2014, a decrease of 60 basis points. Base rent per square foot for the Company’s core properties was $21.32 at June 30, 2015, an enhance of 1.5% contrast to $21.00 per square foot at June 30, 2014. Mall in-line store sales at the Company’s core properties were $358 per square foot for the twelve months ending June 30, 2015 contrast to $342 per square foot for the twelve months ending June 30, 2014, an enhance of 4.7%. The properties attained in the January 15, 2015 merger with Glimcher Realty Trust (“Glimcher”) are comprised of in these metrics for both periods stated. These stated metrics exclude the impact of non-core properties. Non-core properties are comprised of seven assets that contribute 4% of the Company’s total NOI. These properties represent assets that generate positive cash flow, are unencumbered, but offer limited long-term growth potential.

Washington Prime Group Inc. (NYSE:WPG.WI) operates independently of Simon Property Group Inc. as of May 28, 2014.

DISCLAIMER:

This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.

All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.

Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.

Leave a Reply

Your email address will not be published. Required fields are marked *